Clobetasol Propionate Ophthalmic Nanosuspension ( Formosa Pharmaceuticals)

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameClobetasol Propionate Ophthalmic Nanosuspension ( Formosa Pharmaceuticals)
Drug Alias NameBYQLOVIAPP-13007EYEN-530GPN-00833
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPostoperative inflammationOcular inflammationPain +[5] 
Global Approved IndicationsPostoperative inflammationPain, Postoperative
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/03/04
Country/TerritoryUnited StatesPuerto RicoMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesActivus Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesFormosa Pharmaceuticals IncEyenovia IncJingde Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsPostoperative inflammationOcular inflammationPain +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A